Publications

Browse our publications catalogue to learn about our research.

KIR2DS2 expression identifies NK cells with enhanced anticancer activity

Matthew Blunt, Mark Cragg, Amber Doyle, Jack, Graham Fisher, Salim Khakoo, Francesco Forconi, Peter Johnson, Marta Ewa Polak, Lara, Victoria Graham, Andres Vallejo Pulido, Rebecca Fulton & Matthew Carter, 2022, The Journal of Immunology, 209 (2)(2), 379-390

DOI: 10.4049/jimmunol.2101139

Type: article

Characterization of metabolic alterations of chronic lymphocytic leukemia in the lymph node microenvironment

Zhenghao Chen, Helga Simon-Molas, Gaspard Cretenet, Beatriz Valle-Argos, Lindsay D. Smith, Francesco Forconi, Bauke V. Schomakers, Michel van Weeghel, Dean J. Bryant, Jaco A.C. van Bruggen, Fleur S. Peters, Jeffrey C. Rathmell, Gerritje J.W. van der Windt, Aron P. Kater, Graham Packham & Eric Eldering, 2022, Blood, 140(6), 630-643

DOI: 10.1182/blood.2021013990

Type: article

B-cell receptor signaling induces proteasomal degradation of PDCD4 via MEK1/2 and mTORC1 in malignant B cells

Joe Taylor, Sarah Wilmore, Sophie Marriot, Karly-Rai Rogers-Broadway, Rachel Fell, Annabel R. Minton, Tom Branch, Meg Ashton-Key, Mark Coldwell, Freda K. Stevenson, Francesco Forconi, Andrew J. Steele, Graham Packham & Alison Yeomans, 2022, Cellular Signalling, 94

DOI: 10.1016/j.cellsig.2022.110311

Type: article

B-cell receptor dependent phagocytosis and presentation of particulate antigen by chronic lymphocytic leukemia cells

Annabel Rachel Minton, Lindsay D. Smith, Dean J. Bryant, Jonathan Strefford, Francesco Forconi, Freda Stevenson, David Tumbarello, Edd James, Geir Åge Løset, Ludvig A. Munthe, Andrew J. Steele & Graham Packham, 2022, Exploration of Targeted Anti-Tumor Therapy, 3(1), 37-49

DOI: 10.37349/etat.2022.00070

Type: article

Biological and clinical insight from analysis of the tumor B-cell 2 receptor structure and function in chronic lymphocytic Leukemia

Francesco Forconi, Stuart Lanham & Giorgia Chiodin, 2022, Cancers, 28(3)

DOI: 10.3390/cancers14030663

Type: article

Selinexor enhances NK cell activation against malignant B cells via downregulation of HLA-E

Jack, Graham Fisher, Salim Khakoo, Mark Cragg, Francesco Forconi, Peter Johnson, Amber Doyle, christopher Walker, yosef landesman & Matthew Blunt, 2021, Frontiers in Oncology

DOI: 10.3389/fonc.2021.785635

Type: article

Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior

Giorgia Chiodin, Joel D Allen, Dean Bryant, Philip Rock, Enrica Antonia Martino, Beatriz Valle-Argos, Patrick J Duriez, Yasunori Watanabe, Isla Henderson, James S Blachly, Katy J McCann, Jonathan C Strefford, Graham Packham, Teunis Bh Geijtenbeek, Carl Figdor, George Wright, Louis Michael Staudt, Richard Burack, Thomas Bowden, Max Crispin, Freda Kathryn Stevenson & Francesco Forconi, 2021, Blood, 138(17), 1570-1582

DOI: 10.1182/blood.2021012052

Type: article